Nok Therapeutics, Inc. NKTP
The SEC does not publish structured financial data (XBRL) for Nok Therapeutics, Inc., so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 1-SA | Semiannual report pursuant to regulation a | Sep 28, 2026 | Jun 30, 2026 |
| 1-U | Current report | Jul 15, 2026 | Jul 14, 2026 |
| 1-U | Current report | Jun 3, 2026 | May 28, 2026 |
| D/A | Filing | May 1, 2026 | — |
| D/A | Filing | May 1, 2026 | — |
| 1-K | Filing | Apr 30, 2026 | Dec 31, 2025 |
| D/A | Filing | Apr 22, 2026 | — |
| D/A | Filing | Apr 22, 2026 | — |
| D/A | Filing | Apr 22, 2026 | — |
| D | Filing | Mar 26, 2026 | — |
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NKTP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Cranberry Twp, PA
- SEC CIK
- 2038166
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.